| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |